Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07451769) titled 'Selective Activation of the Adrenomedullin Receptors in Migraine' on Feb. 28.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Danish Headache Center
Condition:
Migraine
Brain Diseases
Central Nervous System Diseases
Adrenomedullin
Pain
Peptides
Neuropeptides
Signs and Symptoms
Intervention:
Drug: Adrenomedullin
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 10, 2026
Target Sample Size: ...